What is the efficacy of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation?
A study by Jones et al. (2014) found that the efficacy of rivaroxaban compared with warfarin was comparable in patients with peripheral artery disease and non-valvular atrial fibrillation. The results of the study showed that there was no significant difference in the rate of stroke or systemic embolism between the two groups, and that there was no difference in the rates of major bleeding or life-threatening bleeding between the two groups.